Baxter International | BAX - Interest Expense On Debt


Baxter International reported $78M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
Abbott USD 299M 231M Jun/2026
AngioDynamics USD 102K 2K Sep/2025
Artivion USD 5.53M 589K Dec/2025
AtriCure USD 1.21M 159K Mar/2026
Baxter International USD 78M 20M Mar/2026
Becton, Dickinson and Co. USD 132M 17M Jun/2026
Boston Scientific USD 96M 6M Jun/2026
Cooper Companies USD 21.5M 600K Jun/2026
Dexcom USD 3.1M 1.1M Mar/2026
Edwards Lifesciences USD 30M 5.9M Jun/2026
Fresenius EUR 81M 5M Sep/2025
Globus Medical USD 5.49B 48.7M Jun/2026
Halozyme Therapeutics USD 5.59M 80K Jun/2026
ICU Medical USD 18.53M 2.11M Mar/2026
Inogen 1.03M 384K Mar/2025
Insulet USD 11M 3.7M Jun/2026
Integra LifeSciences USD 22.99M 529K Jun/2026
Intuitive Surgical USD 20.88B 765.6M Jun/2026
J&J USD 43M 25M Mar/2026
Laboratory Of America USD 61.1M 6M Jun/2026
Medtronic USD 186M 10M Jun/2026
Merit Medical Systems USD 12.12M 5.59M Jun/2026
Quest Diagnostics USD 69M 2M Sep/2025
Smith & Nephew USD 69M 1000K Dec/2025
Stryker USD 47.93B 1.64B Jun/2026
Tandem Diabetes Care USD 1.15B 808K Jun/2026
Teleflex USD 27.95M 2.24M Jun/2026
Terumo JPY 1.48B 51M Jun/2026
Zimmer Biomet Holdings USD 22.8B 22.73B Jun/2026